Picture Supply : AP COVID-19 vaccine: Zydus Cadila will get DGCI nod for section 3 medical trials of Pegylated Interferon Alpha-2 Drug agency Zydus Cadila on Friday mentioned it has acquired the approval from the Medication Controller Normal of India (DCGI) to begin section...